The Patent Finder

Terms ending in 2035

Sanofi

Every in-force patent on Sanofi's record whose computed term ends in 2035, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 10,610,595Stabilized Pharmaceutical Formulations of Insulin Analogues And/Or Insulin Derivatives
In force
 · High confidence
SanofiIn forceHigh confidence
US 10,155,934Novel Cytochrome P450 Polypeptide with Increased Enzyme Activity
In force
 · Medium confidence
Euroapi FranceIn forceMedium confidence
US 12,570,761ANTI-CEACAM5 Antibodies and Uses Thereof
In force
 · Medium confidence
SanofiIn forceMedium confidence
US 10,363,379Safety Device for a Medicament Container
In force
 · High confidence
SanofiIn forceHigh confidence
US 11,305,069Safety Device for a Medicament Container
In force
 · Medium confidence
SanofiIn forceMedium confidence
US 10,201,662Injection Device and Assembly Method
In force
 · High confidence
Auto Injection Technologies LLCIn forceHigh confidence
US 9,765,307Novel Cytochrome P450 Polypeptide with Increased Enzyme Activity
In force
 · High confidence
Euroapi FranceIn forceHigh confidence
US 11,827,871Small Volume Bioreactors With Substantially Constant Working Volumes and Associated Systems and Methods
In force
 · High confidence
Massachusetts Institute of TechnologyIn forceHigh confidence
US 10,010,679Injection Device
In force
 · High confidence
SanofiIn forceHigh confidence
US 10,370,449Methods for Treating Skin Infection by Administering an IL-4R Antagonist
In force
 · High confidence
Sanofi BiotechnologyIn forceHigh confidence
60 more term ends in 2035 · Pro
10 of 70 patents shown. Soonest term end first, then patent number.
Pro members see all 70.
Upgrade to Pro
59 of these are in force and held by Sanofi.
Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 17, 2026 · includes USPTO assignment data published Nov 16, 2026, status data published Nov 17, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited